Silicosis and Dust Disease Claims in Scotland
In recent years, a condition that many people associate with the industrial past has re-emerged as one of the most pressing occupational health crises in the United Kingdom. Silicosis — a progressive and incurable lung disease caused by the inhalation of fine crystalline silica dust — is being diagnosed in significant and increasing numbers among workers in industries that most people would not immediately associate with the Victorian-era hazards of coal mining and stone quarrying. Engineered stone kitchen worktop fabricators, construction workers using power tools on concrete and masonry, tunnelling and quarrying operatives, ceramic and pottery workers, and workers in a range of other industries are developing silicosis at ages and in circumstances that have shocked occupational health specialists and generated significant regulatory and legal attention.
But silicosis is only one of a family of dust-related lung diseases — the pneumoconioses — that continue to affect Scottish workers and former workers across multiple industries. Coalworkers' pneumoconiosis, also known as black lung disease. Asbestosis — the fibrotic lung disease caused by asbestos inhalation, distinct from mesothelioma. Byssinosis from cotton dust exposure. Occupational asthma from sensitising dust exposure. Chronic obstructive pulmonary disease accelerated by workplace dust exposure. Each of these conditions represents a distinct medical diagnosis, a distinct pattern of occupational exposure, and a distinct set of legal and evidential challenges in the context of a compensation claim.
Understanding what these conditions are, how they arise, what the legal framework for claiming compensation looks like, and what the specific challenges of dust disease litigation in Scotland involve is essential for any worker or former worker who has developed a dust-related lung condition and who is considering whether they have a claim.
What Is Silicosis?
Crystalline silica is one of the most abundant minerals on earth. It is found in sand, sandstone, granite, slate, concrete, brick, mortar, and a wide range of other materials that are worked, cut, ground, drilled, and shaped in construction, quarrying, mining, and manufacturing. When these materials are disturbed — by cutting, grinding, drilling, or blasting — fine respirable particles of crystalline silica are released into the air. When inhaled, these particles penetrate deep into the lung tissue where they cannot be expelled. The body's immune response to the silica particles triggers a process of chronic inflammation and progressive fibrosis — the formation of scar tissue — that destroys the lung's capacity to function.
Silicosis takes several clinical forms depending on the intensity and duration of exposure. Chronic silicosis — the most common form — develops after ten or more years of exposure to lower concentrations of respirable silica dust. It is characterised by progressive breathlessness, reduced exercise tolerance, and a pattern of nodular fibrosis visible on chest imaging. Accelerated silicosis develops after five to ten years of exposure to higher concentrations and progresses more rapidly. Acute silicosis — the most rapidly progressive and most lethal form — can develop within weeks or months of exposure to very high concentrations of respirable silica and may be rapidly fatal.
There is no cure for silicosis. The fibrosis, once established, does not reverse with removal from exposure. Treatment is palliative — managing symptoms, preventing and treating respiratory infections, providing oxygen therapy for severe disease — but cannot halt the progression of the underlying fibrosis. In its more severe forms, silicosis causes profound disability and premature death.
Silicosis also significantly increases the risk of developing other serious conditions including pulmonary tuberculosis, lung cancer, autoimmune diseases, and kidney disease. The association between silicosis and lung cancer is particularly important — silica has been classified as a Group 1 human carcinogen by the International Agency for Research on Cancer, and the excess risk of lung cancer in silica-exposed workers is well established.
The Re-emergence of Silicosis: Engineered Stone
The most significant recent development in silicosis in Scotland and across the UK involves the fabrication of engineered stone — composite stone products containing very high concentrations of crystalline silica that are used for kitchen worktops, bathroom vanity units, and other domestic and commercial surfaces. Engineered stone products, sold under brand names including Silestone, Caesarstone, and Compac, contain crystalline silica concentrations of up to ninety percent — significantly higher than natural stone — and when cut, shaped, and polished using power tools, they generate respirable silica dust at concentrations many times higher than those produced by equivalent work on natural stone.
The fabrication of engineered stone worktops — cutting to size, routing the edges, creating cutouts for sinks and hobs, polishing the surface — produces extremely high levels of respirable crystalline silica dust if adequate dust control measures are not in place. Workers in engineered stone fabrication workshops who were not provided with adequate respiratory protective equipment, who worked without adequate local exhaust ventilation, and who were not protected by water suppression systems during cutting and grinding have been developing silicosis at alarming rates and at relatively young ages.
Cases of silicosis among engineered stone workers have been reported in increasing numbers in the UK over recent years, following earlier outbreaks that had already been identified in Australia, Israel, and Spain. Many of the affected workers in Scotland and across the UK are relatively young — in their thirties and forties — and some have developed severe and rapidly progressive disease requiring lung transplantation or causing premature death. The human cost of this entirely preventable occupational health crisis is profound, and the legal and regulatory response is ongoing.
The Health and Safety Executive has published specific guidance on the control of silica dust in engineered stone fabrication, and the Control of Substances Hazardous to Health Regulations 2002 impose specific obligations on employers in this sector to assess and control silica dust exposure. The exposure limit for respirable crystalline silica under the Workplace Exposure Limits published by the HSE is 0.1 milligrams per cubic metre averaged over an eight hour working day — a limit that is regularly exceeded in uncontrolled engineered stone fabrication.
Coal Workers' Pneumoconiosis
Coal workers' pneumoconiosis — known colloquially as black lung or coalminers' lung — is a fibrotic lung disease caused by the inhalation of coal dust. Scotland's coal mining industry, centred on the Lanarkshire, Ayrshire, and Fife coalfields, employed hundreds of thousands of workers through the nineteenth and twentieth centuries, exposing generations of miners to high concentrations of coal dust in the underground working environment.
Coal workers' pneumoconiosis takes two main forms. Simple pneumoconiosis is characterised by small nodular opacities on chest imaging and is associated with mild to moderate breathlessness and reduced exercise tolerance. Progressive massive fibrosis — the more severe form — involves the development of large areas of fibrosis in the upper zones of the lungs that cause severe respiratory disability and significantly shortened life expectancy.
The recognition of coal workers' pneumoconiosis as an occupational disease is longstanding — it has been a prescribed industrial disease for Industrial Injuries Disablement Benefit purposes for decades. Many former Scottish miners have claimed IIDB for pneumoconiosis, and civil compensation claims for pneumoconiosis have been pursued through the Scottish courts for generations.
The challenges specific to coalminers' pneumoconiosis claims in Scotland include the identification and tracing of the former employer — the National Coal Board or its predecessors and successors in the nationalised and subsequently privatised coal industry — and the insurer or compensation scheme applicable to claims against the Coal Board. Claims against the National Coal Board and its successor British Coal are handled through specific arrangements that differ from claims against private employers, and specialist legal advice is needed to navigate these arrangements.
Asbestosis
Asbestosis is a fibrotic lung disease caused by the inhalation of asbestos fibres — distinct from mesothelioma, which is a malignancy of the pleural or peritoneal lining, and from pleural plaques and pleural thickening. Asbestosis involves progressive scarring of the lung tissue itself, causing increasing breathlessness, reduced lung function, and in severe cases respiratory failure and death.
Asbestosis typically develops after prolonged and heavy asbestos exposure — it is more commonly associated with high exposure occupations such as lagging and insulation work, shipbuilding, and asbestos manufacturing than with the lower-level exposures that may cause pleural disease. The diagnosis requires the presence of diffuse bilateral pulmonary fibrosis consistent with asbestosis on high-resolution CT imaging, a history of significant asbestos exposure, and typically a latency period of at least ten years between first exposure and diagnosis.
Asbestosis claims in Scotland arise from the same industries and the same historical exposure circumstances as mesothelioma and pleural disease claims — the Clyde shipyards, the construction industry, the power generation sector, and the range of other industries that used asbestos extensively through the twentieth century. The legal framework, the tracing of former employers and insurers through ELTO, the date of knowledge analysis, and the limitation considerations are all essentially the same as for other asbestos-related disease claims.
The key distinction between asbestosis claims and mesothelioma claims, from the litigation perspective, is the causation analysis. Mesothelioma can be caused by very low levels of asbestos exposure and the Fairchild principle — establishing liability on the basis of material contribution to risk — applies. Asbestosis is a dose-related disease — its development requires a significant cumulative dose of asbestos fibres — and the causation analysis involves establishing that the exposure attributable to the defendant employer was sufficient to materially contribute to the development of the condition.
Occupational Asthma
Occupational asthma is a form of asthma caused by sensitisation to a substance encountered in the workplace. It is distinct from pre-existing asthma that is exacerbated by workplace conditions — it is a new-onset condition caused by a specific occupational exposure. Occupational asthma is one of the most common occupational diseases in the UK, affecting workers in a wide range of industries.
In the construction and manufacturing sectors, common causes of occupational asthma include isocyanates from spray painting and polyurethane foams, wood dust from woodworking machinery, flour dust in the baking industry, latex proteins in healthcare workers using latex gloves, laboratory animal allergens, and a range of other sensitising agents. Once a worker has been sensitised to a particular substance, even very low subsequent exposures can trigger asthmatic reactions.
Occupational asthma claims in Scotland require medical evidence establishing the diagnosis — including specific workplace challenge testing or immunological testing to identify the causative sensitiser — and evidence that the employer failed to prevent the sensitising exposure through adequate hazard identification, control measures, and health surveillance. The Control of Substances Hazardous to Health Regulations 2002 impose specific obligations on employers to assess and control exposure to respiratory sensitisers and to implement health surveillance programmes for workers exposed to substances that can cause occupational asthma.
Chronic Obstructive Pulmonary Disease and Mixed Dust Exposure
Chronic obstructive pulmonary disease — COPD — is a progressive lung disease characterised by airflow limitation and breathlessness that is caused primarily by cigarette smoking but that can also be caused or accelerated by occupational dust exposure. For workers who have been exposed to high levels of coal dust, grain dust, textile dust, or a range of other occupational dusts, the occupational exposure may have caused or materially contributed to the development of COPD in addition to or independent of any smoking history.
COPD claims in Scotland — particularly those arising from coal dust exposure in former miners and from construction dust exposure in building workers — raise specific causation challenges because smoking is the dominant cause of COPD in the general population and the contribution of occupational dust exposure must be separated from the contribution of smoking to establish the employer's liability for the occupationally attributable component.
Medical expert evidence in COPD claims must address the respective contributions of smoking and occupational dust exposure to the overall severity of the COPD. The established methodology for this apportionment involves a respiratory physician who reviews the claimant's smoking history, their occupational exposure history, and the pattern of their COPD, and produces an opinion on the proportion of the overall disability attributable to the occupational exposure. Where a significant occupational component is established, a compensation claim may be viable for that component even where smoking was also a significant contributor.
The Legal Framework for Dust Disease Claims
The legal framework for dust disease claims in Scotland follows the same general structure as other occupational disease claims — the employer's common law duty of care, the specific statutory duties imposed by the COSHH Regulations and other relevant legislation, and the Hunter v Hanley standard for establishing breach of duty.
The employer's duty to protect workers from dust exposure arises as soon as the risk of harm from that exposure is foreseeable. For silica dust exposure, the risks of silicosis have been known for well over a century — silicosis was among the first occupational diseases to be recognised and regulated, and the dust control obligations in industries such as quarrying, mining, and ceramics have a very long history. An employer in the construction or engineered stone industry who failed to control silica dust exposure in recent decades cannot claim ignorance of the risk.
For coal dust exposure, the knowledge of pneumoconiosis risk was established even earlier, and the National Coal Board and its predecessors were long aware of the relationship between coal dust exposure and lung disease. For asbestosis, as discussed in the asbestos essays, the duty arose from at least the 1930s in relation to high-level asbestos exposure and from the 1960s for lower-level exposure.
The COSHH Regulations 2002 impose specific duties on employers to assess the risk to health from substances hazardous to health — including all forms of dust that are hazardous to health — to prevent or adequately control exposure, to ensure that control measures are properly used and maintained, to provide information and training, and to implement appropriate health surveillance. Workplace Exposure Limits published by the HSE provide specific numerical limits for a range of dusts including respirable crystalline silica and coal dust. Exceeding these limits is a breach of the COSHH Regulations and strong evidence of negligence.
The Prescribed Disease System and Industrial Injuries Disablement Benefit
Many dust-related lung diseases are listed as prescribed diseases in the Social Security (Industrial Injuries)(Prescribed Diseases) Regulations 1985, making them eligible for Industrial Injuries Disablement Benefit from the Department for Work and Pensions. Prescribed dust diseases include silicosis, coalworkers' pneumoconiosis, asbestosis, byssinosis, and occupational asthma from specific causative agents.
IIDB for prescribed dust diseases provides weekly benefit payments based on the assessed percentage of disablement — the degree to which the condition has reduced the claimant's working capacity. The benefit is not means-tested and does not affect the right to bring a civil compensation claim.
The Pneumoconiosis etc. (Workers' Compensation) Act 1979 provides additional statutory lump sum payments for workers disabled by dust-related lung diseases where the employer has ceased trading and a civil claim is not possible. Payments under the 1979 Act are lower than civil damages but provide a measure of compensation in cases where the civil route is unavailable.
Claiming IIDB and any available 1979 Act payments is an important step for any worker with a dust-related lung disease, both because these payments provide immediate financial support and because the assessment of disablement for IIDB purposes produces audiological and medical evidence that is relevant to the civil claim.
The Claims Process
The dust disease claims process in Scotland follows the same broad structure as other industrial disease claims — specialist legal advice, gathering of employment and exposure history, medical evidence, identification of former employers and their insurers through ELTO and supplementary investigation, letter of claim, negotiation, and if necessary court proceedings.
The employment and exposure history is the foundation of the claim. A detailed account of every employer, every workplace, every process performed, every dust-generating activity undertaken, and the availability or otherwise of dust controls and respiratory protective equipment during each period of employment provides the framework within which the medical and technical evidence is assessed.
Medical evidence from a consultant respiratory physician with specific expertise in occupational lung disease is required to establish the diagnosis, assess the severity of the condition, attribute the condition to the occupational exposure, and provide a prognosis. In COPD claims involving a smoking history, the respiratory physician will also address the apportionment between occupational and smoking contributions.
In silicosis and coal dust claims, evidence from an occupational hygienist — a specialist in workplace exposure assessment — may be needed to establish the likely dust concentrations in the relevant working environments and to assess the cumulative dust dose attributable to each employer.
The ELTO database search and supplementary investigation to identify former employers and their insurers follows the process described in the ELTO essay. For recent claims involving engineered stone workers, the employers are typically still in existence and the insurance tracing exercise is straightforward. For historical claims involving former miners, shipyard workers, and heavy industry workers, the tracing exercise may be more complex.
Compensation in Dust Disease Claims
Compensation in a Scottish dust disease claim covers solatium for the pain, suffering, and loss of amenity of the condition — assessed by reference to the Judicial College Guidelines for respiratory disease — and special damages for all financial losses caused by the disability.
The solatium assessment for dust diseases reflects the severity of the respiratory disability, the breathlessness and exercise limitation caused by the condition, any associated conditions such as pulmonary hypertension or cor pulmonale in advanced disease, the psychological impact of a progressive and incurable condition, and the impact on the quality of daily life. In the most severe cases — advanced silicosis requiring lung transplantation, severe progressive massive fibrosis causing profound respiratory failure — the solatium awards reflect the catastrophic and life-limiting nature of the condition.
Special damages may include past and future wage loss where the respiratory disability has affected or ended the claimant's ability to work, the cost of medications and medical treatment, care costs where the disability is severe enough to require domestic or personal assistance, the cost of oxygen therapy in severe disease, and all other financial losses flowing directly from the condition.
The Bottom Line
Silicosis and dust disease claims in Scotland arise from failures — historical and continuing — to protect workers from the well-understood and long-recognised risks of dust inhalation in the workplace. The law of Scotland provides a clear and enforceable route to compensation for workers whose lungs have been damaged by dust they should never have been allowed to breathe.
The claims are complex — requiring specialist medical evidence, occupational hygiene expertise, ELTO searches, and in many cases the navigation of multiple statutory compensation schemes alongside the civil claim. But they are claims that succeed, that are brought by workers and former workers across Scotland's industrial sectors from the Clyde shipyards to the modern construction sites and the engineered stone fabrication workshops, and that deliver compensation that acknowledges the gravity of what those workers have suffered.
The dust was preventable. The disease was foreseeable. The rights of the workers it damaged are real and they are enforceable — and no worker in Scotland who has developed a dust-related lung condition as a result of their employment should assume, without seeking specialist legal advice, that their time has passed or their case cannot be made.